Modified nanobodies improve imaging of NETosis in neutrophils, highlighting therapeutic implications.
Neutrophil extracellular traps (NETs) are pivotal in the immune response, trapping and neutralizing pathogens. The process of NET formation, or NETosis, is a critical innate immune response mechanism implicated in diverse physiological and pathological processes, including infections, chronic inflammation, and cancer. Accurate imaging of NETosis is essential for unraveling its mechanisms and therapeutic implications, although limitations of specificity and flexibility remain. In this article, we present modified nanobodies targeting Ly6C/G and histones for imaging of NETosis. Single‐domain antibodies (VHHs), also known as nanobodies, targeting Ly6C/G specifically bind to neutrophils, and anti‐histone nanobodies selectively target NET‐associated histones, enabling NETosis monitoring. These nanobodies are engineered to optimize fluorescent probe labeling and can enable high‐resolution visualization of NETosis through whole‐body fluorescence tomography and/or intravital microscopy. Our approach offers an alternative for expanding the existing NETosis imaging toolkit. © 2025 Wiley Periodicals LLC. Basic Protocol 1 : Cloning, cytoplasmic expression, and purification of proteins Basic Protocol 2 : Fluorophore binding assay Support Protocol 1 : Analysis by gel staining and immunoblotting Support Protocol 2 : In‐gel tryptic digestion and sample preparation for LC‐MS/MS analysis Support Protocol 3 : SpyCatcher003/SpyTag003 binding assay
No takes yet. Share an insight, caveat, or question.
Gutu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: